Our results reinforced previous observations, Armstrong et al. 2004,12 in that the presence of the FLT3 mutation in hyperdiploid ALL did not affect the clinical outcome as the patient responded well to chemotherapy and achieved continuous complete remission (CCR). The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.